3500 LENOX RD. NE, ATLANTA, GA
Director Passing - Lynne Fahey McGrath, M.P.H., Ph.D. Dies
Annual Meeting Held; Seven Directors Appointed by Stockholders
News
Alzamend Neuro Enters $3 Million At-the-Market Sales Agreement
Director Passing - Andrew H. Woo, M.D., Ph.D. of Alzamend Neuro, Inc.
Amendments to Articles of Incorporation or Bylaws
FY 2025
Q3
Q2
Q1
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities
Registration Statement for Securities Offered under a Shelf Registration
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Amended Initial Statement of Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload